Skip to main content

CIRM cuts ten grants

The California Institute for Regenerative Medicine (CIRM) linkurl:announced;https://www.cirm.ca.gov/press/pdf/2007/1207007.pdf today that it is eliminating ten grant applications from consideration to avoid breaking its conflict of interest rules regarding grant applications and accompanying letters of support. "CIRM has opted to act conservatively by refraining from considering these applications," the release said, "and the agency will take steps to clarify future requirements for institutiona

Written byBob Grant
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
The California Institute for Regenerative Medicine (CIRM) linkurl:announced;https://www.cirm.ca.gov/press/pdf/2007/1207007.pdf today that it is eliminating ten grant applications from consideration to avoid breaking its conflict of interest rules regarding grant applications and accompanying letters of support. "CIRM has opted to act conservatively by refraining from considering these applications," the release said, "and the agency will take steps to clarify future requirements for institutional letters of commitment." According to an article in today's __San Francisco Chronicle__, deans at four California universities apparently breached CIRM's conflict of interest rules by submitting letters of support with CIRM grant applications from their respective schools. CIRM did not identify the institutions, which are vying for a cut of $85 million in new faculty awards. This incident follows a previous linkurl:conflict;https://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2007/12/07/BAOTTQ0JO.DTL&feed=rss.bayarea involving board member and Burnham Institute of Medical Research CEO John Reed. Deans at the University of California, San Francisco, UCLA, the University of Southern California, and the University of California, San Diego are CIRM board members and therefore prohibited from participating in granting activities involving their institutions. The __Chronicle__ article says that "sources close to the grant-making process" have said that grant applications from these four institutions have been flagged for violating CIRM's conflict of interest rules and are in danger of being thrown out. Jesse Reynolds, a policy analyst and CIRM critic, said that conflicts such as these are unsurprising given the fact that the CIRM board is made up of administrators at the very California institutions that are vying for CIRM funding. "The structure of the board, I believe, was a recipe for disaster," he told __The Scientist__.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Improving rAAV Production for Viral Vector Manufacturing

Improving rAAV Production for Viral Vector Manufacturing

cytiva logo
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Scientist holding a clear 384-well PCR microplate in a laboratory

What Dictates PCR Success Before Amplification Begins?

Integra Logo
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo